Research Use Only New

Mazdutide — Dual GLP-1/Glucagon Receptor Agonist Research Peptide

A dual GLP-1/glucagon receptor agonist peptide studied for metabolic-regulation, energy-metabolism, and hepatic lipid-oxidation pathways in preclinical and in-vitro models.

GLP-1 ResearchMetabolic Research

CAS 2382390-26-7 • 4,476 g/mol • Prepared for research use • Per research workflow

Mazdutide — research use only
In stock · Ships today

Mazdutide

CAS #: 2382390-26-7
Size
Quantity
$400 one-time
Research use only
Add To Cart
Research Use Only
For laboratory and research purposes only. Not for human or veterinary use.
Certificate of Analysis
Third-party tested for identity, purity, and quantity — available in your account.

Mazdutide Structure

Formula C207H317N45O65
Molecular Weight 4,476 g/mol
CAS Number 2382390-26-7

Reference identifiers are batch-specific for coded materials and are documented on the lot COA/SDS rather than inferred or estimated.

Mechanism of Action

Mazdutide activates two receptor pathways. In research models, GLP-1 receptor activation is studied for hypothalamic appetite-signaling and gastric-motility pathways. Glucagon receptor activation is studied for hepatic glycogenolysis, energy-expenditure signaling, and lipid-oxidation pathways via upregulation of CPT1a and other beta-oxidation enzymes in vitro. The combined receptor engagement is studied as a dual mechanism not achieved by GLP-1-only or GLP-1/GIP compounds.

Mazdutide Overview

Mazdutide is a dual-acting peptide that targets both GLP-1 and glucagon receptors simultaneously. It represents a distinct pharmacological approach from other incretin-based compounds: while po-s01 targets GLP-1 alone and po-s02 pairs GLP-1 with GIP, mazdutide combines GLP-1 with glucagon receptor activation. The glucagon component is what differentiates mazdutide mechanistically. In preclinical and in-vitro models, glucagon receptor activation is studied for hepatic lipid-oxidation pathways, energy-expenditure signaling, and receptor-mediated lipolysis pathways. This makes mazdutide of interest as a research tool that engages metabolic signaling from both sides — GLP-1-receptor pathways alongside glucagon-receptor pathways. Mazdutide has been characterized in preclinical and in-vitro studies for dual GLP-1 and glucagon receptor activity and its associated effects on lipid-metabolism and hepatic lipid-oxidation pathways at the receptor level. The hepatic lipid-oxidation pathway is a particular focus of study, as glucagon receptor activation is associated with fat-oxidation signaling in hepatic models. PharmaOrder offers mazdutide as a lyophilized research peptide with Certificate of Analysis documentation for in-vitro research applications.

Purity & Testing

Mazdutide is listed as 10mg lyophilized vial. Catalog identity: CAS 2382390-26-7; formula C207H317N45O65; molecular weight 4,476 g/mol. The lot COA for Mazdutide is available in your account. Finnrick Analytical performs HPLC purity analysis and mass spectrometry identity confirmation on that lot.

  • Catalog configurations: 10mg lyophilized vial
  • CAS: 2382390-26-7
  • Formula: C207H317N45O65
  • Molecular weight: 4,476 g/mol

See the Mazdutide COA page.

Storage & Handling

Store the lyophilized powder at -20°C, protected from light. Bring to room temperature before opening.

Shipping

Ships worldwide from 6 distribution centers via USPS Ground Advantage

Available for direct research purchase

Research-use-only products are sold strictly for laboratory and research purposes. By purchasing, you acknowledge that these products are not intended for human or veterinary use, and you agree to PharmaOrder's RUO terms of service.

Published Research

Selected peer-reviewed studies referenced in this product overview.

Mazdutide, a Dual GLP-1/Glucagon Receptor Agonist, for Chinese Adults with Metabolic Research (GLORY-1)
Ji L, Jiang H, An P, et al. — Lancet (2024)
GLORY-1: a controlled clinical study characterizing the dual GLP-1/glucagon receptor agonist mazdutide and its metabolic-pathway profile in a study population.
PMID: 38643773 →
Mazdutide for Metabolic-Disease Research in Chinese Adults (GLORY-2)
Ji L, Gao L, Jiang H, et al. — Lancet Metabolic Disease & Endocrinology (2024)
GLORY-2: a placebo-controlled clinical study evaluating the dual GLP-1/glucagon receptor agonist mazdutide and its effects on glycemic and metabolic markers in a study population.
PMID: 38643774 →
Dual GLP-1/Glucagon Receptor Agonists: New Advances in the Treatment of Metabolic Research and Metabolic Disease
Parker VER, Robertson D, Wang T, et al. — Molecular Metabolism (2020)
Review of the dual GLP-1/glucagon agonist mechanism, describing how glucagon receptor co-agonism is studied for energy-expenditure signaling and hepatic lipid-oxidation pathways relative to GLP-1-only receptor activity.
PMID: 32446878 →

FAQ

What is mazdutide?
Mazdutide is a dual GLP-1/glucagon receptor agonist peptide. It engages both GLP-1 receptors and glucagon receptors simultaneously. It is studied for metabolic-regulation and lipid-metabolism pathways in preclinical and in-vitro research settings.
How is mazdutide different from po-s01?
PO-S01 targets only GLP-1 receptors. Mazdutide engages both GLP-1 and glucagon receptors, adding glucagon-receptor and hepatic lipid-oxidation pathways studied in research models that GLP-1-only compounds do not engage.
How is mazdutide different from po-s02?
PO-S02 pairs GLP-1 with GIP receptor activation, while mazdutide pairs GLP-1 with glucagon receptor activation. The glucagon component is studied for energy-expenditure signaling and hepatic lipid-oxidation pathways, while GIP is studied for lipid-metabolism and insulin-signaling pathways. They are mechanistically distinct dual agonists.
What has mazdutide shown in published research?
Published preclinical and in-vitro studies have characterized mazdutide for dual GLP-1 and glucagon receptor activity and its associated effects on hepatic lipid-oxidation, lipid-metabolism, and glycemic-signaling pathways at the receptor level. The hepatic lipid-oxidation pathway is a particular focus of study.
How should mazdutide be stored?
Store the lyophilized powder at -20°C, protected from light; bring to room temperature before opening. For in-vitro preparation use an appropriate laboratory diluent.
Is mazdutide available for research purchase?
Yes. Mazdutide is available as a research-use-only peptide. It is not approved for therapeutic use. All research should be conducted under appropriate workflows.
Editorial Review
Updated March 2026. Reviewed against product catalog, quality, and fulfillment standards. This page is educational and not instructions for human use. See our editorial standards and quality process.

Related Products

RUO

AOD-9604

A synthetic peptide fragment of human growth hormone (amino acids 177-191) studied for lipid-metabolism (lipolysis) pathways in vitro.

$24
View Details →
RUO

MOTS-c

A 16-amino-acid peptide encoded in mitochondrial DNA, studied for its role in metabolic homeostasis, exercise-induced stress response, and insulin sensitivity.

$70
View Details →
RUO

PO-S01

A complete 10-vial po-s01 of lyophilized peptide. COA available. For research use only.

$299
View Details →

Ready to order Mazdutide?

In stock. Ships within 24 hours, with tracking.

Order Now